MELISSA LAUGHREY: Open Payments
NPI 1689458994 · WINFIELD, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,996 in 102 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $2,041 · 2025 $1,996
Food & beverage: $1,996
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 20 | $559 |
| Neurocrine BioSciences, Inc. | 24 | $413 |
| ABBVIE INC. | 17 | $261 |
| Teva Pharmaceuticals USA, Inc. | 12 | $192 |
| Otsuka America Pharmaceutical, Inc. | 5 | $116 |
| Alkermes, Inc. | 4 | $80 |
| Corium, LLC | 4 | $66 |
| Vanda Pharmaceuticals Inc. | 3 | $62 |
| Lundbeck LLC | 3 | $54 |
| Janssen Pharmaceuticals, Inc | 3 | $52 |
Products named: CAPLYTA, INGREZZA, VRAYLAR, REXULTI, AUSTEDO XR, UZEDY, ARISTADA, Azstarys.
Industry payments across KS — which companies pay providers there.
